Arrowstreet Capital’s Compugen CGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEN
AIM
NAMA
RSCM
BHC
TFCM
Arrowstreet Capital's CGEN Position: Q4 2020 in Review
Arrowstreet Capital sold out of Compugen (CGEN) in Q4 2020, closing a stake of 14,000 shares — an estimated $228K sold.
Arrowstreet Capital first reported a position in CGEN in Q4 2019 and held it in 2 quarters. The position peaked at $228K in Q3 2020. 101 funds tracked by Wall St. Rank hold CGEN as of Q4 2020.
- Arrowstreet Capital reported no remaining Compugen position as of Q4 2020 after selling out during the quarter.
- Arrowstreet Capital sold 14,000 Compugen shares in Q4 2020, an estimated $228K.
- Arrowstreet Capital first reported a position in Compugen in Q4 2019 and held it in 2 quarters.
- Arrowstreet Capital's Compugen position peaked at $228K in Q3 2020.
- 101 funds tracked by Wall St. Rank held Compugen as of Q4 2020.
Based on Arrowstreet Capital's 13F filing for Q4 2020, filed 12 Feb 2021.